Rosenblatt maintains Dolby Laboratories at Buy, lowers price target to $75 from $80
Rosenblatt kept Dolby Laboratories at Buy but reduced its price target to $75 from $80, a 6.2% cut. The new target suggests a 27.5% upside from the Nov 17 close of $58.82, according to the firm.







